Explore life science & biotech companies in Oxford, home to one of the world's leading biotechnology and life science clusters.
PET radiopharmaceutical diagnostics for cancer imaging
Blue Earth Diagnostics Limited is a molecular imaging company developing and commercialising PET radiopharmaceuticals for cancer diagnosis and treatment planning. The company…
Closed-loop implantable neuromodulation for peripheral nervous system disorders
Amber Therapeutics is a medical technology company developing fully implantable, adaptive neuromodulation therapies for functional disorders of the peripheral nervous system. The…
Biotech venture builder co-creating and scaling drug discovery companies
Molecule to Medicine (MTM) is a biotech venture builder that co-creates, builds, and scales drug discovery companies within a shared operational ecosystem, combining drug…
CSF-1R antibody therapy for tenosynovial giant cell tumour
SynOx Therapeutics is a late-stage biopharmaceutical company developing emactuzumab, a humanised monoclonal antibody targeting CSF-1R, for the treatment of tenosynovial giant cell…
Cancer immunotherapies targeting novel antigens from the dark genome
Enara Bio is a clinical-stage biopharmaceutical company developing cancer immunotherapies directed against Dark Antigens, a class of cancer-specific targets derived from…
Specialist CRO for drug and agrochemical metabolite synthesis and characterisation
Hypha Discovery is a specialist contract research organisation supporting pharmaceutical and agrochemical companies worldwide. The company produces and purifies drug and…
Science and innovation campus in Oxford's Cowley district
ARC Oxford is an 88-acre science and innovation campus located in Cowley, Oxford, operating as part of the Advanced Research Clusters network owned by Brookfield. Formerly Oxford…
Small molecule GPR65 inhibitors restoring immune response in solid tumours
Pathios Therapeutics is a clinical-stage drug discovery company developing small molecule inhibitors of GPR65, a pH-sensing G protein-coupled receptor that drives…
Precision oncology drugs and vaccines for cold tumours
IngenOx Therapeutics Limited is a clinical-stage biopharmaceutical company developing precision oncology drugs and cancer vaccines for difficult-to-treat tumours. The company…
Non-viral gene therapy platform enabling durable nuclear DNA delivery
Gramics Bio develops a gene therapy platform solving a key limitation of lipid nanoparticle delivery: enabling therapeutic DNA to reach the cell nucleus for durable expression…
ADC pipeline targeting mutant stem cells in blood cancers
Alethio Therapeutics Limited is a preclinical-stage biotechnology company developing antibody-drug conjugates for myeloproliferative neoplasms, a group of chronic blood cancers.…
T cell immunotherapies for infectious disease, cancer and autoimmunity
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing antigen-specific T cell immunotherapies for chronic infectious diseases, autoimmune conditions,…